These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 32952667)

  • 21. Light-Responsive and Dual-Targeting Liposomes: From Mechanisms to Targeting Strategies.
    Agiba AM; Arreola-Ramírez JL; Carbajal V; Segura-Medina P
    Molecules; 2024 Jan; 29(3):. PubMed ID: 38338380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endogenous stimuli-responsive linkers in nanoliposomal systems for cancer drug targeting.
    Faal Maleki M; Jafari A; Mirhadi E; Askarizadeh A; Golichenari B; Hadizadeh F; Jalilzadeh Moghimi SM; Aryan R; Mashreghi M; Jaafari MR
    Int J Pharm; 2019 Dec; 572():118716. PubMed ID: 31705978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Smart Drug Delivery System and Its Clinical Potential.
    Liu D; Yang F; Xiong F; Gu N
    Theranostics; 2016; 6(9):1306-23. PubMed ID: 27375781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aptamer-Based Smart Targeting and Spatial Trigger-Response Drug-Delivery Systems for Anticancer Therapy.
    Park D; Lee SJ; Park JW
    Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
    Du JZ; Li HJ; Wang J
    Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polysaccharide-based tumor microenvironment-responsive drug delivery systems for cancer therapy.
    Wu Q; Hu Y; Yu B; Hu H; Xu FJ
    J Control Release; 2023 Oct; 362():19-43. PubMed ID: 37579973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptide Sequence-Dominated Enzyme-Responsive Nanoplatform for Anticancer Drug Delivery.
    Li Y; Du L; Wu C; Yu B; Zhang H; An F
    Curr Top Med Chem; 2019; 19(1):74-97. PubMed ID: 30686257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimuli-responsive nanoscale drug delivery systems for cancer therapy.
    Li L; Yang WW; Xu DG
    J Drug Target; 2019 Apr; 27(4):423-433. PubMed ID: 30173577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surface-anchored tumor microenvironment-responsive protein nanogel-platelet system for cytosolic delivery of therapeutic protein in the post-surgical cancer treatment.
    Fan X; Wang K; Lu Q; Lu Y; Liu F; Li L; Li S; Ye H; Zhao J; Cao L; Zhang H; He Z; Sun J
    Acta Biomater; 2022 Dec; 154():412-423. PubMed ID: 36280028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy.
    Avramović N; Mandić B; Savić-Radojević A; Simić T
    Pharmaceutics; 2020 Mar; 12(4):. PubMed ID: 32218326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insights into stimuli-responsive diselenide bonds utilized in drug delivery systems for cancer therapy.
    Shi Z; Liu J; Tian L; Li J; Gao Y; Xing Y; Yan W; Hua C; Xie X; Liu C; Liang C
    Biomed Pharmacother; 2022 Nov; 155():113707. PubMed ID: 36122520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell microenvironment stimuli-responsive controlled-release delivery systems based on mesoporous silica nanoparticles.
    Zhu CL; Wang XW; Lin ZZ; Xie ZH; Wang XR
    J Food Drug Anal; 2014 Mar; 22(1):18-28. PubMed ID: 24673901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
    Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
    Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor Microenvironment-Based Stimuli-Responsive Nanoparticles for Controlled Release of Drugs in Cancer Therapy.
    Zhou W; Jia Y; Liu Y; Chen Y; Zhao P
    Pharmaceutics; 2022 Oct; 14(11):. PubMed ID: 36365164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effective Combination between 3D Cancer Models and Stimuli-Responsive Nanoscale Drug Delivery Systems.
    Foglietta F; Serpe L; Canaparo R
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficient, enzyme responsive and tumor receptor targeting gelatin nanoparticles decorated with concanavalin-A for site-specific and controlled drug delivery for cancer therapy.
    Vaghasiya K; Ray E; Singh R; Jadhav K; Sharma A; Khan R; Katare OP; Verma RK
    Mater Sci Eng C Mater Biol Appl; 2021 Apr; 123():112027. PubMed ID: 33812642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA response element-based smart drug delivery systems for precise drug release.
    Xuan J; Wang Z; Huang Y; Liu Y; Han Y; Li M; Xiao M
    Biomater Sci; 2024 Jul; 12(14):3550-3564. PubMed ID: 38832670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Intracellular and Extracellular Microenvironment of Tumor Site: The Trigger of Stimuli-Responsive Drug Delivery Systems.
    Jing X; Hu H; Sun Y; Yu B; Cong H; Shen Y
    Small Methods; 2022 Mar; 6(3):e2101437. PubMed ID: 35048560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems.
    Karimi M; Ghasemi A; Sahandi Zangabad P; Rahighi R; Moosavi Basri SM; Mirshekari H; Amiri M; Shafaei Pishabad Z; Aslani A; Bozorgomid M; Ghosh D; Beyzavi A; Vaseghi A; Aref AR; Haghani L; Bahrami S; Hamblin MR
    Chem Soc Rev; 2016 Mar; 45(5):1457-501. PubMed ID: 26776487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment.
    Chen B; Dai W; He B; Zhang H; Wang X; Wang Y; Zhang Q
    Theranostics; 2017; 7(3):538-558. PubMed ID: 28255348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.